Abbott Laboratories buy Argus
Start price
31.01.25
/
50%
€123.82
Target price
31.01.26
-
Performance (%)
-13.68%
Price
12.12.25
€106.88
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -13.68%. This prediction currently runs until 31.01.26. The prediction end date can be changed by Argus at any time. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -0.447% | -0.447% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Argus for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) was upgraded by analysts at Argus to a "strong-buy" rating.
Ratings data for ABT provided by MarketBeat